银华中证创新药产业ETF发起式联接C(012782)资产负债表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
资产 |
银行存款 |
- |
- |
- |
- |
结算备付金 |
- |
56,928.41 |
73,919.92 |
110,196.04 |
存出保证金 |
473,555.28 |
54,097.05 |
34,788.81 |
41,473.72 |
交易性金融资产 |
191,875,697.45 |
213,471,100.44 |
89,269,597.75 |
101,211,047.37 |
其中:股票投资 |
- |
- |
- |
- |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
- |
- |
- |
- |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
3,032,303.03 |
2,219,061.43 |
1,485,258.94 |
1,373,500.70 |
其他资产 |
- |
- |
- |
- |
资产总计 |
211,527,291.66 |
278,809,639.00 |
98,014,751.44 |
109,929,900.00 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
1,035,678.41 |
46,241,498.78 |
453,642.42 |
145,780.52 |
应付赎回款 |
6,992,770.38 |
5,654,902.53 |
2,679,590.22 |
1,981,376.66 |
应付管理人报酬 |
4,930.16 |
4,832.46 |
2,296.44 |
2,626.82 |
应付托管费 |
493.02 |
483.23 |
229.63 |
262.69 |
应付销售服务费 |
11,736.37 |
9,325.83 |
5,973.30 |
6,598.80 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
75,152.32 |
150,100.77 |
65,078.90 |
130,129.85 |
负债合计 |
8,120,760.66 |
52,061,143.60 |
3,206,810.91 |
2,266,775.34 |
所有者权益 |
实收基金 |
310,552,838.75 |
391,690,259.80 |
185,749,875.48 |
159,544,284.74 |
未分配利润 |
-107,146,307.75 |
-164,941,764.40 |
-90,941,934.95 |
-51,881,160.08 |
所有者权益合计 |
203,406,531.00 |
226,748,495.40 |
94,807,940.53 |
107,663,124.66 |
负债及所有者权益总计 |
211,527,291.66 |
278,809,639.00 |
98,014,751.44 |
109,929,900.00 |